7 research outputs found
Additional file 1 of BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
Supplementary Material 1: Figure 1. Micrographs of U87 and GL261 glioma cells. Microscopic pictures of the two cell lines treated with different concentrations of Doxo are shown at day 5. Bar = 400µm
Additional file 6 of BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
Supplementary Material 6: Video 2b. Growth of U87 cells treated with 200nM Doxo
Additional file 2 of BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
Supplementary Material 2: Video 1a. Growth of GL261 cells without treatment
Additional file 7 of BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
Supplementary Material 7: Video 2c. Growth of U87 cells treated with 800nM Doxo
Additional file 4 of BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
Supplementary Material 4: Video 1c. Growth of GL261 cells treated with 50nM Doxo
Additional file 5 of BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
Supplementary Material 5: Video 2a. Growth of U87 cells without treatment
Additional file 3 of BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
Supplementary Material 3: Video 1b. Growth of GL261 cells treated with 12.5nM Doxo